IL6 and neoplasm: Herfs M reported that anti-IL-6 therapy in vivo significantly reduced epithelial hyperplasia and squamous metaplasia which is associated with airway obstruction in patients with COPD and is a risk factor for tumor transformation and epithelial remodeling [55].